An assessment of the long-term developmental and behavioral teratogenicity of prenatal nicotine exposure

Julia Vaglenova1, Sanjay Birru, Noemi M Pandiella

  • 1Department of Pharmacal Sciences, Auburn University Harrison School of Pharmacy, 401 Walker Building, Auburn University, Auburn, AL 36849, USA.

Insights

Prenatal nicotine exposure in rats caused long-term developmental and behavioral deficits, including hyperactivity and cognitive impairment. These effects were more pronounced in females and persisted into adulthood.

Area of Science:

  • Neuroscience
  • Developmental Psychology
  • Toxicology

Background:

  • Maternal tobacco use during pregnancy is linked to adverse child development.
  • Nicotine, a primary component of tobacco, is a known teratogen.
  • Understanding nicotine's developmental impact is crucial for public health.

Purpose of the Study:

  • To investigate the long-term effects of prenatal nicotine exposure on offspring behavior and development in Sprague-Dawley rats.
  • To examine the influence of maternal nicotine withdrawal and cross-fostering on developmental outcomes.
  • To establish a model for studying neurodevelopmental effects of prenatal teratogens.

Main Methods:

  • Administered nicotine (6mg/kg/day) or saline to pregnant Sprague-Dawley rats.
  • Assessed offspring behavior across various developmental stages, including exploration, locomotion, anxiety, and learning/memory.
  • Utilized cross-fostering to differentiate effects of prenatal exposure from maternal care.

Main Results:

  • Prenatal nicotine exposure resulted in growth retardation, hyperactivity, and impaired adaptation to new environments.
  • Offspring exhibited increased anxiety during adolescence and cognitive deficits in adulthood, with females showing more severe effects.
  • Cross-fostering indicated that maternal behavior and nicotine withdrawal did not fully account for growth or cognitive deficits, but impacted exploratory behaviors and anxiety.

Conclusions:

  • Prenatal nicotine exposure induces significant, long-lasting developmental and behavioral teratogenic effects.
  • The study provides a valuable model for investigating the mechanisms underlying neurodevelopmental deficits caused by prenatal nicotine and other teratogens.
  • Findings highlight the critical need to prevent maternal smoking during pregnancy due to severe neurodevelopmental consequences.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
Drugs Acting on Autonomic Ganglia: Stimulants01:23

Drugs Acting on Autonomic Ganglia: Stimulants


Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...